What is the recommended timing for administering Tranexamic acid (TXA) to prevent excessive blood loss during a cesarean section (CS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Tranexamic Acid Administration During Cesarean Section

For prophylactic prevention of excessive blood loss during cesarean section, administer 1 gram of tranexamic acid intravenously over 10 minutes prior to skin incision. 1

Prophylactic Administration Timing

The optimal timing for TXA in cesarean section is before skin incision when used prophylactically to prevent excessive blood loss:

  • Administer 1 g IV over 10 minutes prior to skin incision for non-cardiac major surgery, including cesarean section 1
  • This prophylactic approach differs fundamentally from therapeutic use for established postpartum hemorrhage 1
  • Dose adjustment may be needed based on body weight: 1 g for patients <90 kg and 1.5 g for patients >90 kg 2

Critical Distinction: Prophylaxis vs. Treatment

It is essential to distinguish between two different clinical scenarios with different timing requirements:

Prophylactic Use (Prevention)

  • Given before skin incision to prevent excessive bleeding during the planned cesarean section 1, 2
  • Reduces mean blood loss by approximately 25-30% compared to placebo 2, 3
  • Decreases intraoperative blood loss from approximately 520 mL to 390 mL 2
  • Significantly reduces postoperative hemorrhage and need for blood transfusion 3, 4

Therapeutic Use (Treatment of Established PPH)

  • Must be given within 3 hours of bleeding onset when treating established postpartum hemorrhage 1, 5
  • Efficacy decreases by 10% for every 15 minutes of delay 5
  • A second 1 g dose can be given if bleeding continues after 30 minutes or restarts within 24 hours 1
  • The WOMAN trial demonstrated reduced bleeding-related mortality when given within 3 hours for established PPH 1

Evidence Supporting Pre-Incision Prophylactic Timing

Multiple high-quality studies support the pre-incision timing for prophylaxis:

  • Intraoperative blood loss is significantly reduced when TXA is given 10-20 minutes before skin incision 2, 6, 4, 7
  • Postoperative blood loss within 24 hours is also significantly decreased 3, 6
  • The incidence of postoperative anemia and blood transfusion requirements are substantially lower 3
  • No adverse maternal or neonatal effects have been documented with this timing 2, 4, 7

Important Caveats

Do not confuse prophylactic cesarean section dosing with postpartum hemorrhage treatment:

  • The 3-hour window applies only to established bleeding/PPH, not prophylactic use 1, 8
  • TXA is not indicated for intrauterine miscarriage, first or second trimester pregnancy loss, or bleeding from retained products before viable delivery 8
  • Giving TXA beyond the 3-hour window for established PPH may be harmful 8

Dosing Algorithm for Cesarean Section

For elective or scheduled cesarean section (prophylaxis):

  • 1 g IV over 10 minutes before skin incision 1, 2
  • Consider 1.5 g if body weight >90 kg 2

If postpartum hemorrhage develops during or after cesarean:

  • 1 g IV over 10 minutes within 3 hours of bleeding onset 1
  • Second dose of 1 g if bleeding continues after 30 minutes or restarts within 24 hours 1

Renal Impairment Consideration

  • Dose adjustment is recommended in patients with impaired renal function based on serum creatinine levels 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Uso del Ácido Tranexámico en Sangrado Ginecológico

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2011

Guideline

Emergency Management of Intrauterine Miscarriage with Hemodynamic Instability

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.